Narrative Update • May 19
Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Healthcare Services Industry Analysis
UpdatedMay 27, 2026
DataAggregated Company Financials
Companies11
- 7D1.0%
- 3M-9.7%
- 1Y-8.7%
- YTD-5.6%
The Healthcare Services industry is up 1.0% in the last week, with Bradsaúde up 3.3%. Meanwhile, Hapvida Participações e Investimentos actually underperformed within the industry, shrinking 5.0% in the last week. In contrast, the industry has lost 8.7% in the last 12 months. As for the next few years, earnings are expected to grow by 28% per annum.
Industry Valuation and Performance
Has the Brazilian Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 27 May 2026 | R$141.5b | R$143.1b | R$679.8m | 15.2x | 208.1x | 1x |
| Fri, 24 Apr 2026 | R$117.3b | R$142.9b | R$1.1b | 16.1x | 103.7x | 0.8x |
| Sun, 22 Mar 2026 | R$111.6b | R$144.2b | R$2.0b | 15.4x | 55.1x | 0.8x |
| Tue, 17 Feb 2026 | R$128.6b | R$141.9b | R$588.8m | 18.6x | 218.5x | 0.9x |
| Thu, 15 Jan 2026 | R$122.3b | R$141.9b | R$588.8m | 17.1x | 207.7x | 0.9x |
| Sat, 13 Dec 2025 | R$129.1b | R$141.9b | R$588.8m | 16.9x | 219.3x | 0.9x |
| Mon, 10 Nov 2025 | R$142.9b | R$142.0b | R$1.7b | 12.9x | 84.5x | 1x |
| Wed, 08 Oct 2025 | R$131.8b | R$140.1b | R$1.4b | 13.4x | 95.8x | 0.9x |
| Fri, 05 Sep 2025 | R$130.0b | R$140.1b | R$1.4b | 13.2x | 94.5x | 0.9x |
| Sun, 03 Aug 2025 | R$111.0b | R$140.1b | R$871.1m | 12.4x | 127.4x | 0.8x |
| Tue, 01 Jul 2025 | R$119.0b | R$139.7b | R$877.7m | 11.4x | 135.6x | 0.9x |
| Thu, 29 May 2025 | R$127.1b | R$139.7b | R$877.7m | 11.2x | 144.8x | 0.9x |
| Sat, 26 Apr 2025 | R$111.0b | R$137.9b | R$740.0m | 11.5x | 150.1x | 0.8x |
| Mon, 24 Mar 2025 | R$102.8b | R$139.7b | R$3.9b | 16.6x | 26.1x | 0.7x |
| Wed, 19 Feb 2025 | R$107.8b | R$136.0b | R$2.9b | 11.9x | 37.4x | 0.8x |
| Fri, 17 Jan 2025 | R$99.1b | R$136.0b | R$2.9b | 11.2x | 34.4x | 0.7x |
| Sun, 15 Dec 2024 | R$101.1b | R$136.0b | R$2.9b | 11.6x | 35.1x | 0.7x |
| Tue, 12 Nov 2024 | R$112.8b | R$133.9b | R$2.6b | 11.7x | 43.5x | 0.8x |
| Thu, 10 Oct 2024 | R$121.4b | R$134.1b | R$2.5b | 12.4x | 48.5x | 0.9x |
| Sat, 07 Sep 2024 | R$135.5b | R$134.1b | R$2.5b | 13.7x | 54.2x | 1x |
| Mon, 05 Aug 2024 | R$120.8b | R$132.6b | R$2.3b | 13.3x | 51.8x | 0.9x |
| Wed, 03 Jul 2024 | R$113.8b | R$132.2b | R$2.4b | 12.9x | 48.4x | 0.9x |
| Fri, 31 May 2024 | R$120.8b | R$132.2b | R$2.3b | 14.3x | 51.6x | 0.9x |
| Sun, 28 Apr 2024 | R$115.2b | R$129.5b | R$1.4b | 16.7x | 82.7x | 0.9x |
| Tue, 26 Mar 2024 | R$121.4b | R$122.7b | R$863.4m | 19.3x | 140.6x | 1x |
| Thu, 22 Feb 2024 | R$119.4b | R$122.1b | R$729.3m | 22.8x | 163.7x | 1x |
| Sat, 20 Jan 2024 | R$131.0b | R$124.2b | R$902.0m | 24.2x | 145.2x | 1.1x |
| Mon, 18 Dec 2023 | R$139.7b | R$124.2b | R$902.0m | 27.1x | 154.8x | 1.1x |
| Wed, 15 Nov 2023 | R$127.8b | R$123.1b | R$969.7m | 22.4x | 131.8x | 1x |
| Fri, 13 Oct 2023 | R$129.1b | R$115.3b | R$753.8m | 25.1x | 171.3x | 1.1x |
| Sun, 10 Sep 2023 | R$139.3b | R$115.3b | R$753.8m | 25.2x | 184.8x | 1.2x |
| Tue, 08 Aug 2023 | R$162.6b | R$106.9b | R$741.2m | 29.1x | 219.3x | 1.5x |
| Thu, 06 Jul 2023 | R$151.5b | R$106.3b | R$737.3m | 30.9x | 205.4x | 1.4x |
| Sat, 03 Jun 2023 | R$140.2b | R$106.3b | R$748.7m | 25.3x | 187.2x | 1.3x |
Price to Earnings Ratio
187.2x
Current Industry PE
- Investors are optimistic on the Brazilian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 208x which is higher than its 3-year average PE of 117x.
- The industry is trading close to its 3-year average PS ratio of 0.95x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 3.2% per year over the last three years.
- Meanwhile revenues for these companies have grown 10% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Brazilian Healthcare industry?
| BR Market | -0.27% | |
| Healthcare | 0.89% | |
| Healthcare Services | 1.02% | |
| Healthcare Distributors | 4.09% | |
| Healthcare Services | 3.09% | |
| Managed Healthcare | 2.09% | |
| Healthcare Facilities | -0.018% | |
Industry PE
- Investors are most optimistic about the Managed Healthcare industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 33.7%, which is higher than its past year's earnings growth of 0.5% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 57% over the next 5 years.
- This is better than its past earnings growth rate of 1.2% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings decline by 35% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SAUD3 Bradsaúde | R$13.79 | 3.3% +R$1.3b | 23.7% | PE71.4x | |
| ONCO3 Oncoclínicas do Brasil Serviços Médicos | R$1.46 | 16.8% +R$234.8m | -71.1% | PS0.3x | |
| FLRY3 Fleury | R$16.05 | 1.6% +R$135.9m | 24.8% | PE13.7x | |
| DASA3 Diagnósticos da América | R$3.14 | 1.3% +R$50.0m | 93.8% | PS0.4x | |
| VVEO3 CM Hospitalar S/A | R$1.25 | 7.8% +R$28.4m | -9.4% | PE19.6x |
